These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
535 related articles for article (PubMed ID: 29102270)
21. Early Renin-angiotensin System Blockade Improved Short-term and Longterm Renal Outcomes in Systemic Lupus Erythematosus Patients with Antiphospholipid-associated Nephropathy. Yue C; Li G; Wen Y; Li X; Gao R J Rheumatol; 2018 May; 45(5):655-662. PubMed ID: 29449503 [TBL] [Abstract][Full Text] [Related]
22. Has RAAS Blockade Reached Its Limits in the Treatment of Diabetic Nephropathy? Majewski C; Bakris GL Curr Diab Rep; 2016 Apr; 16(4):24. PubMed ID: 26879307 [TBL] [Abstract][Full Text] [Related]
23. Sodium-glucose cotransporter-2 inhibitors and non-steroidal mineralocorticoid receptor antagonists: Ushering in a new era of nephroprotection beyond renin-angiotensin system blockade. Shenoy SV; Nagaraju SP; Bhojaraja MV; Prabhu RA; Rangaswamy D; Rao IR Nephrology (Carlton); 2021 Nov; 26(11):858-871. PubMed ID: 34176194 [TBL] [Abstract][Full Text] [Related]
24. Cardiorenal protection during chronic renin-angiotensin-aldosterone system suppression: evidences and caveats. Ruiz-Hurtado G; Ruilope LM Eur Heart J Cardiovasc Pharmacother; 2015 Apr; 1(2):126-31. PubMed ID: 27533982 [TBL] [Abstract][Full Text] [Related]
25. The RAAS in the pathogenesis and treatment of diabetic nephropathy. Ruggenenti P; Cravedi P; Remuzzi G Nat Rev Nephrol; 2010 Jun; 6(6):319-30. PubMed ID: 20440277 [TBL] [Abstract][Full Text] [Related]
26. Clinical Outcomes of Renin-Angiotensin-Aldosterone Blockade in Patients With Advanced Chronic Kidney Disease: A Systematic Review and Meta-analysis. Vendeville N; Lepage MA; Festa MC; Mavrakanas TA Can J Cardiol; 2024 Sep; 40(9):1718-1728. PubMed ID: 38458564 [TBL] [Abstract][Full Text] [Related]
27. Does renin-angiotensin aldosterone system blockade exacerbate contrast-induced nephropathy in patients with chronic kidney disease? A prospective 50-month Mayo Clinic study. Onuigbo MA; Onuigbo NT Ren Fail; 2008; 30(1):67-72. PubMed ID: 18197546 [TBL] [Abstract][Full Text] [Related]
28. Trends in Kidney Function Outcomes Following RAAS Inhibition in Patients With Heart Failure With Reduced Ejection Fraction. McCallum W; Tighiouart H; Ku E; Salem D; Sarnak MJ Am J Kidney Dis; 2020 Jan; 75(1):21-29. PubMed ID: 31303349 [TBL] [Abstract][Full Text] [Related]
29. Effect of renin-angiotensin-aldosterone system blockade in adults with diabetes mellitus and advanced chronic kidney disease not on dialysis: a systematic review and meta-analysis. Nistor I; De Sutter J; Drechsler C; Goldsmith D; Soler MJ; Tomson C; Wiecek A; Donciu MD; Bolignano D; Van Biesen W; Covic A Nephrol Dial Transplant; 2018 Jan; 33(1):12-22. PubMed ID: 29106631 [TBL] [Abstract][Full Text] [Related]
30. Does blockade of the Renin-Angiotensin-aldosterone system slow progression of all forms of kidney disease? Lattanzio MR; Weir MR Curr Hypertens Rep; 2010 Oct; 12(5):369-77. PubMed ID: 20703958 [TBL] [Abstract][Full Text] [Related]
31. Renin-angiotensin II-aldosterone system blockers and time to renal replacement therapy in children with CKD. Abraham AG; Betoko A; Fadrowski JJ; Pierce C; Furth SL; Warady BA; Muñoz A Pediatr Nephrol; 2017 Apr; 32(4):643-649. PubMed ID: 27826732 [TBL] [Abstract][Full Text] [Related]
32. Disputes in the Treatment of Diabetic Nephropathy: The Dual Blockade of Renin-Angiotensin System. Grolla E; Bonanni L; Cutolo A; Presotto F; Dalla Vestra M Exp Clin Endocrinol Diabetes; 2016 Jun; 124(6):361-6. PubMed ID: 27219891 [TBL] [Abstract][Full Text] [Related]
33. Effect of dual compared to no or single renin-angiotensin system blockade on risk of renal replacement therapy or death in predialysis patients: PREPARE-2 study. Voskamp PWM; Dekker FW; van Diepen M; Hoogeveen EK; J Am Soc Hypertens; 2017 Oct; 11(10):635-643. PubMed ID: 28802945 [TBL] [Abstract][Full Text] [Related]
34. Sequential RAAS blockade: is it worth the risk? Persson F; Rossing P Adv Chronic Kidney Dis; 2014 Mar; 21(2):159-65. PubMed ID: 24602465 [TBL] [Abstract][Full Text] [Related]
35. The role of renin-angiotensin-aldosterone system in the progression of chronic kidney disease. Remuzzi G; Perico N; Macia M; Ruggenenti P Kidney Int Suppl; 2005 Dec; (99):S57-65. PubMed ID: 16336578 [TBL] [Abstract][Full Text] [Related]
36. Renal failure and concurrent RAAS blockade in older CKD patients with renal artery stenosis: an extended Mayo Clinic prospective 63-month experience. Onuigbo MA; Onuigbo NT Ren Fail; 2008; 30(4):363-71. PubMed ID: 18569908 [TBL] [Abstract][Full Text] [Related]
37. Aggressive blood pressure reduction and renin-angiotensin system blockade in chronic kidney disease: time for re-evaluation? Sarafidis PA; Ruilope LM Kidney Int; 2014 Mar; 85(3):536-46. PubMed ID: 24048382 [TBL] [Abstract][Full Text] [Related]
38. Dual Renin-Angiotensin-Aldosterone System Inhibition for the Treatment of Diabetic Kidney Disease: Adverse Effects and Unfulfilled Promise. El-Haddad B; Reule S; Drawz PE Curr Diab Rep; 2015 Oct; 15(10):70. PubMed ID: 26275442 [TBL] [Abstract][Full Text] [Related]
39. Renin-angiotensin-aldosterone system inhibition: overview of the therapeutic use of angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, mineralocorticoid receptor antagonists, and direct renin inhibitors. Mercier K; Smith H; Biederman J Prim Care; 2014 Dec; 41(4):765-78. PubMed ID: 25439533 [TBL] [Abstract][Full Text] [Related]
40. [Renoprotective treatments : renin-angiotensin-aldosterone system blockade and beyond]. Esnault V Rev Prat; 2024 Jun; 74(6):s19-s22. PubMed ID: 39011717 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]